Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

Bibliographic Details
Title: Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
Authors: Ju, Wu‐tong, Liu, Ying, Wang, Li‐zhen, Li, Jiang, Ren, Guo‐xing, Sun, Jian, Tu, Wen‐yong, Hu, Yong‐jie, Ji, Tong, Yang, Wen‐jun, Li, Jun, He, Yue, Wang, Yan‐an, Zhang, Chen‐ping, Zhong, Lai‐ping, Zhang, Zhi‐yuan
Source: Cancer communications. 41(3):279-283
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116917380.0x000001&indx=1&recIds=ETOCvdc_100116917380.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:25233548
Published in:Cancer communications
Language:English